(R)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid, 95.0%, 2.5g

3-Fluoro-2-(methoxymethyl)aniline, 1g

1-ethyl-N-methyl-4-piperidinamine, 95.0%, 250mg

3-Aminotetrahydrofuran>97.0%(GC)1g

4-Chloro-3',4'-(ethylenedioxy)benzophenone, 97.0%, 1g

3'-Methylpropiophenone, 96.0%, 1g

3-(Perfluoro-n-butyl)-1,2-propenoxide, 97.0%, 25g

4,5-Dimethyl-phthalic acid anhydride, 98.0%, 1g

Chloroacetic acid ethyl ester, >=98%, for synthesis, 250 ml, glass packaging

TRIS, 500 g, plastic

Fasiglifam, 98.94%, 10mg

50 ml medicine bottle glass brown PP 28 round

tert-Butyl 3,3-dimethylpiperazine-1-carboxylate hydrochloride, 97%, 250mg